Atlas Trials

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Clinical trial NCT07203352 · RECRUITING

Trial details

NCT number
NCT07203352
Sponsor
Nanfang Hospital, Southern Medical University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2025-10-01
Primary completion
2026-12-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.